Science & Medicine
Home | Current Issue | Archives | Subscriptions | Contact Us

Log In | Search | Author Index | Advertising

Epidermal growth factor receptor in cancer therapy

Mikkel W. Pedersen, Hans S. Poulsen
From: Science & Medicine: Volume 8 Number 4: Page 206 (August 2002)

View Full TextAdd To BasketPurchase Images

Abstract: The epidermal growth factor receptor (EGFR) has been the focus of recent attention because of the key role it plays in several human cancers. While the normal receptor is involved in the regulation of cell proliferation, survival, and differentiation, mutations of this receptor can render it constitutively phosphorylated, constantly activated and able to promote tumor-enhancing signaling cascades. One of these mutations, EGFRvIII, occurs in a broad range of human cancers but not in normal cells, making it an ideal target for anti-cancer therapy. Several therapies targeting this receptor are nearing clinical usage, withmany other strategies exploiting the EGFR system in development.

Back to Table of Contents



Science & Medicine, Inc.
P.O. Box 313, Narberth, PA 19072
(610) 660-8097       (800) 888-0028
fax (610) 660-0348
e-mail editor@sciandmed.com
See our other journal: Medical Problems of Performing Artists.
Home | Current Issue | Archives | Subscriptions | Contact Us

Log In | Search | Author Index | Advertising

Copyright © 2002-2019, Science & Medicine, Inc.

Powered by Pliner Solutions, Inc.
Web Development by Pliner Solutions, Inc.